The risk of stroke in patients with atrial fibrillation (AF) can be assessed by use of the CHADS2 and the CHA2DS2-VASc score system. We hypothesised that these risk scores and their individual components could also be applied to patients paced for sick sinus syndrome (SSS) to evaluate risk of stroke and death.
Prospective cohort study.
All Danish pacemaker centres and selected centres in the UK and Canada.
Risk factors were recorded prior to pacemaker implantation in 1415 patients with SSS participating in the Danish Multicenter Randomized Trial on Single Lead Atrial Pacing versus Dual Chamber Pacing in Sick Sinus Syndrome (Danpace) trial. Development of stroke was assessed at follow-up visits and by evaluation of patient charts. Mortality was assessed from the civil registration system.
Patients were randomised to AAIR (N = 707) or DDDR pacing (N = 708).
Stroke and death during follow-up.
Mean follow-up was 4.3 ± 2.5 years. In the AAIR group 6.9% patients developed stroke versus 6.1% in the DDDR group (NS). There was a significant association between CHADS2 score and the development of stroke (HR 1.41; 95% CI 1.22 to 1.64, p
Notes
Cites: Chest. 2012 Jun;141(6):1431-4022016485
Cites: N Engl J Med. 2012 Jan 12;366(2):120-922236222
Cites: Ann Intern Med. 2011 Nov 15;155(10):660-7, W20422084332
Cites: Eur Heart J. 2011 Mar;32(6):686-9621300730
Cites: Eur Heart J. 2010 Oct;31(19):2369-42920802247